The Genomic Atlas of Breast Cancer — the non-coding theme

Update News

  • GABC update 2020.06.15
  • GABC update 2019.03.20
  • GABC online 2018.08.09
  • Data collection 2018.04.09

About Us

  • Steven Xi Chen:
    steven.chen@miami.edu
  • Yunpeng Zhang:
    YXZ1418@med.miami.edu
  • Peng Wang:
    wpgqy@163.com
  • Shangwei Ning:
    ningsw@ems.hrbmu.edu.cn
  • Xia Li:
    lixia@hrbmu.edu.cn

Detail


Chr chr17
start 59841266
end 59841337
ID MI0000077
miRNA_name hsa-miR-21
methods qRT-PCR,etc.
regulated up
Function Description Upregulation of miR-21 expression at diagnosis was determined as an average miR-21 expression in healthy women plus 2xSD as described at the Material and Methods. Progression-free survival was compared between patients with and without miR-21 upregulation at diagnosis. Patients with miR-21 upregulation showed shorter progression-free survival, median survivals were 72 vs 86 weeks and Mantel-Cox test p=0.049, Fig
PMID 31030498
year 2019
Title Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer
drug X
circulating V
survival V

CopyRight © University of Miami, USA; Harbin Medical University, China